The abstract reveals that radioresistance involves both extracellular matrix remodeling and changes in adhesion signaling proteins, but how these two processes are coordinated mechanistically is not explained. This coordination likely represents a key vulnerability for therapeutic targeting. Gap type: unexplained_observation Source paper: The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells. (2024, Front Cell Dev Biol, PMID:39149513)
Landscape Summary: How do extensive matrix remodeling changes coordinate with adhesion signaling to drive radioresistance? is a 0.76 priority gap in cancer-biology. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How do extensive matrix remodeling changes coordinate with adhesion signaling to drive radioresistance? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: